Ge Healthcare Company Profile

What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?

GE HEALTHCARE has forty-nine approved drugs.

There are six US patents protecting GE HEALTHCARE drugs.

There are seventy-nine patent family members on GE HEALTHCARE drugs in twenty-five countries and one hundred and twenty-eight supplementary protection certificates in eighteen countries.

Summary for Ge Healthcare

International Patents:	79
US Patents:	6
Tradenames:	57
Ingredients:	38
NDAs:	49
Drug Master File Entries:	5

Drugs and US Patents for Ge Healthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-002	Oct 25, 2013		RX	Yes	Yes	7,270,800		Y	Y
Ge Healthcare	TELEPAQUE	iopanoic acid	TABLET;ORAL	008032-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Ge Healthcare	AMIPAQUE	metrizamide	INJECTABLE;INJECTION	017982-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Ge Healthcare	HYPAQUE-CYSTO	diatrizoate meglumine	SOLUTION;URETHRAL	016403-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Ge Healthcare	AMERSCAN MDP KIT	technetium tc-99m medronate kit	INJECTABLE;INJECTION	018335-001	Aug 5, 1982		DISCN	No	No
Ge Healthcare	XENON XE 133	xenon xe-133	GAS;INHALATION	017256-002	Approved Prior to Jan 1, 1982		DISCN	No	No

Expired US Patents for Ge Healthcare

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ge Healthcare	MPI DMSA KIDNEY REAGENT	technetium tc-99m succimer kit	INJECTABLE;INJECTION	017944-001	May 18, 1982	4,233,285
Ge Healthcare	OMNISCAN	gadodiamide	INJECTABLE;INJECTION	020123-001	Jan 8, 1993	5,560,903
Ge Healthcare	VISIPAQUE 270	iodixanol	INJECTABLE;INJECTION	020808-001	Aug 29, 1997	5,366,722
Ge Healthcare	OMNISCAN	gadodiamide	INJECTABLE;INJECTION	022066-001	Sep 5, 2007	5,560,903
Ge Healthcare	VISIPAQUE 270	iodixanol	INJECTABLE;INJECTION	020351-001	Mar 22, 1996	5,349,085
Ge Healthcare	CERETEC	technetium tc-99m exametazime kit	INJECTABLE;INJECTION	019829-001	Dec 30, 1988	4,615,876

International Patents for Ge Healthcare Drugs

Country	Patent Number	Estimated Expiration
Brazil	0113470
Hungary	S1500007
Australia	2011200667
European Patent Office	2182988
Brazil	PI0408274
Canada	2438032

Supplementary Protection Certificates for Ge Healthcare Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2182988	2015006	Norway		PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822
2957286	2018/046	Ireland		PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: EU/1/17/1179 20170719
2563920	CA 2019 00001	Denmark		PRODUCT NAME: A COMPOUND COMPRISING A MODIFIED OLIGONUCLEOTIDE HAVING A NUCLEOBASE SEQUENCE CONSISTING OF 20 LINKED NUCLEOSIDES ACCORDING TO EP B1 2563920 CLAIM 1 (SEQ ID NO: 80), ...SPECIFICALLY INOTERSEN; AND ITS DERIVATIVES, INCLUDING SODIUM SALTS ...; REG. NO/DATE: EU/1/18/1296 20180710
2822954	18C1035	France		PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625
1874117	SPC/GB14/041	United Kingdom		PRODUCT NAME: DOLUTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING DOLUTEGRAVIR SODIUM; REGISTERED: UK EU/1/13/892/001-006 20140121
0290047	SPC/GB97/078	United Kingdom		PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Ge Healthcare
• Ge Hlthcare Inc